Foundational science, mechanisms of action, formulation, and pharmacology of research peptides.
A research overview of the Semax Nasal Kit and intranasal peptide delivery for laboratory research. Covers nose-to-brain transport, Semax mechanism of action, and preclinical applications.
A research overview of MOTS-c, the 16-amino-acid mitochondrial-derived peptide. Covers AMPK signaling, retrograde mitochondrial-to-nuclear communication, and preclinical metabolic research.
A research overview of KPV (Lys-Pro-Val), the C-terminal tripeptide of α-MSH. Covers mechanism of action, anti-inflammatory signaling, PepT1 transport, and preclinical research applications.
Introduction Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that has attracted significant interest in the research community.
Introduction GHK-Cu is the copper(II)-bound form of a small naturally occurring tripeptide (glycyl-L-histidyl-L-lysine). First identified in the 1970s, it has
Introduction Semax is a synthetic research peptide first developed at the Russian Academy of Sciences. Structurally, it is a heptapeptide
A comprehensive research overview of BPC-157 (Body Protection Compound-157). Covers mechanism of action, preclinical data across GI, musculoskeletal, and neurological models, stability, and sourcing standards.
A comprehensive research overview of retatrutide (LY3437943), the triple GLP-1/GIP/glucagon receptor agonist. Covers mechanism of action, Phase 2 clinical data, receptor pharmacology, and research applications.
